Key Dates

Related Announcements

• October 19, 2023 - Microphysiological Systems to Advance Precision Medicine for AD/ADRD Treatment and Prevention (U54 Clinical Trial Not Allowed). See NOFO RFA-AG-24-040.

Issued by

National Institute on Aging (NIA)

Purpose

This Notice informs potential applicants of a change to the Eligibility Information in Notice of Funding Opportunity (NOFO) RFA-AG-24-040, “Microphysiological Systems to Advance Precision Medicine for AD/ADRD Treatment and Prevention (U54 Clinical Trial Not Allowed).” 

The following information under Part 2, Section III.1 Eligible Applicants of RFA-AG-24-040 has been modified:

Foreign Institutions

Currently reads:

Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed. 

Modified to read (changes shown in bold italics):

Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed. 

All other aspects of this NOFO remain unchanged.

Inquiries

Please direct all inquiries to:

Zane Martin, Ph.D.
National Institute on Aging (NIA)
Phone: 301-827-7130
Email: zane.martin@nih.gov